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A B S T R A C T
With improvements in cancer treatment and supportive care, a growing population of survivors of
childhood cancer at risk for signiﬁcant and potentially life-threatening late effects has been identiﬁed.
To provide a current snapshot of the models of care from countries with varying levels of resources
and health care systems, stakeholders in childhood cancer survivorship clinical care and research
were identiﬁed from 18 countries across ﬁve continents. Stakeholders responded to a survey and
provided a brief narrative regarding the current state of survivorship care. Findings indicate that
among pediatric-age survivors of childhood cancer (allowing for differences in age cutoffs across
countries), resources are generally available, and a large proportion of survivors are seen by a physician
familiar with late effects in most countries. After survivors transition to adulthood, only a minority are
seen by a physician familiar with late effects. Despite the need to improve communication between
pediatric oncology and primary care, only a few countries have existing national efforts to educate
primary care physicians, although many more reported that educational programs are in development.
These data highlight common challenges and potential solutions for the lifelong care of survivors of
childhood cancer. Combining risk-based and patient-oriented solutions for this population is likely to
beneﬁt both providers and patients.
J Clin Oncol 36:2223-2230. © 2018 by American Society of Clinical Oncology
INTRODUCTION
Worldwide, in 2012, 1,212,105 incident cancer
cases were diagnosed among individuals age 0 to
39 years.1With sustained improvements in survival,
the number of long-term survivors of childhood,
adolescent, and young adult cancer continues to
increase.2,3 Even with contemporary cancer treat-
ment, damage to normal tissues and developing
organ systems is sometimes unavoidable. Thus, as
the oncology community has focused on reducing
late effects of cancer therapy, a parallel effort con-
centrated on managing long-term survivors of
cancer has burgeoned.
Since the establishment of the ﬁrst survivor-
ship clinics, models for caring for long-term sur-
vivors have evolved.4-11 To assist clinicians in
managing this high-risk population, guidelines
have been developed and disseminated. Notable
are the efforts by the International Late Effects
of Childhood Cancer Guideline Harmonization
Group (IGHG) to facilitate collaboration across the
globe.12 Numerous observational and intervention
studies are in progress worldwide, with the common
aim of improving the long-term health and well-
being of survivors of childhood, adolescent, and
young adult cancer by optimizing their health care.
The aim of this paper is to provide a snapshot of
survivorship care across countries with varying levels
of resources and health care systems, to illustrate
areas of variation and commonality, and to highlight
key issues encountered by most countries. Different
countries refer to survivorship clinics as long-term
follow-up clinics, late effects clinics, aftercare clinics,
and survivorship clinics. For this article, we have
used the term survivorship clinic to refer to these
types of clinics.
METHODS
We identiﬁed stakeholders from 18 countries across ﬁve
continents to describe childhood cancer survivorship
care in their country. Representatives from selected
countries were solicited, with the goal of illustrating
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variation and practice in health care systems. Each stakeholder was asked to
complete a survey and provide a brief narrative focused on country-speciﬁc
innovations or challenges.
RESULTS
Tables 1, 2, and 3 summarize survey responses. Among pediatric-
age survivors, a large proportion is seen by a physician familiar with
late effects (Table 1). After adulthood, far fewer survivors have access
to a physician familiar with late effects (Table 2). When asked about
efforts to bridge pediatric oncology and primary care providers (PCPs;
Table 3), a few countries cited existing educational programs, although
many more endorsed ongoing development of such programs. In the
following paragraphs, innovation and advances in each country are
brieﬂy described in context with the respective health care systems.
Australia
Australia offers a range of care models within nine tertiary
survivorship clinics. Major challenges are inadequate funding and
limited options for transitioning older survivors.10 To overcome
the tyranny of distance in a sparsely inhabited country, the Sur-
vivorship subcommittee of the Australian and New Zealand
Children’s Haematology and Oncology Group is testing several
electronic interventions to support survivors13 and parents14 and
encourage healthy lifestyles. The Re-engage intervention uses
a nurse specialist and telephone or online platform to interview
survivors who are lost to follow-up. A multidisciplinary panel
reviews the data from these encounters and advises future follow-
up in primary care, nurse-led care, or attendance at a multidisci-
plinary survivorship clinic.
Brazil
Brazilian health care is notoriously heterogeneous. Structured
and well-equipped cancer centers are located mostly in the
southeast and southern states. Unfortunately, 83 million people
live in areas where public health care lacks specialized professionals
and essential technology. The management of survivors of child-
hood cancer is even more disparate: although most of the country
Table 1. Current Care for Survivors of Childhood Cancer Who Are Still Considered Children Among 18 Surveyed Countries
Question AU BR CA CH CZ DE DK FR GB IL IN IT JP NL NZ SE TK US
Health care coverage
Universal or single payer x x x x x x x x x x x x x
Mixed, all children with coverage x x x x
Mixed, most children with coverage
Mixed, many children without coverage x
Primary guideline used
National guideline x x x x x x x x
Mixture x x x x x x x x
IGHG x
Institution speciﬁc x
Long-term survivors seen by physician familiar with late
effects (%)*
Almost all (. 90) x x x x x x x
Most (60-89) x x x x x
About half (40-59) x
Some (10-39) x x x x x
Where are most long-term survivors seen?
. 75% at the cancer center x x x x x x x x x x x x x x x x x
Mixture: 50% center, 50% PCP x
Use a risk-stratiﬁed approach
Yes x x x x x x x x x x x x
No x x x x x x
Children with an SCP (%)
Almost all (. 90) x x x
Most (60-89) x x x x
Approximately half (40-59) x x x x
Some (10-39) x x x x
Just a few (, 10) x x x
APPs
Yes, in almost all programs x
Yes, but only in some programs x x x x x x x
No, country does not have APPs x x x x x x x x x x
Young adult survivors formally transitioned
Yes, in almost all programs x x x
Yes, but only some programs x x x x x
Rarely x x x x x x x x x x
NOTE. Each country has a different cutoff for this age group, such as # 16 years, # 18 years, or # 21 years.
Abbreviations: APP, advanced practice provider (ie, nurse practitioner or physician assistant); AU, Australia; BR, Brazil; CA, Canada; CH, Switzerland; CZ, Czech Republic;
DE, Germany; DK, Denmark; FR, France; GB, Great Britain; IGHG, International Late Effects of Childhood Cancer Guideline Harmonization Group; IL, Israel; IN, India; IT,
Italy; JP, Japan; NL, Netherlands; NZ, New Zealand; PCP, primary care physician; SE, Sweden; SCP, survivorship care plan; TK, Turkey; US, United States.
*Starting 2 to 5 years after the end of therapy.
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struggles with cancer screening and detection, some regions have
pioneered cancer survivorship programs, offering multidisci-
plinary long-term follow-up since the late 1990s. Innovative ini-
tiatives, including a comprehensive evaluation by nine different
professionals in a single visit, have been successful in enhancing
survivor adherence and awareness.
Canada
The province of Ontario has a network of seven multidisci-
plinary clinics for children and adults treated for childhood cancer
that is available and free to all patients. This network has positively
affected emergency room use, as evident by a 19% lower rate of
emergency room visits among survivors with at least one clinic visit
compared with those who never had a survivorship clinic visit.15,16
Other provinces are building analogous programs for lifelong
specialized care for survivors of childhood cancer; however, most
provide specialized survivor care limited to the pediatric years.
Czech Republic
In the Czech Republic, children with cancer are referred to
pediatric cancer centers at university hospitals that offer post-treatment
care in multidisciplinary survivorship clinics. High-risk survi-
vors, such as those who have had hematopoietic cell trans-
plantation, continue follow-up into adulthood at the pediatric
cancer center. Other adult survivors receive survivorship care
plans (SCPs) and are followed in adult primary care or oncology
centers, while retaining the option of visiting the pediatric cancer
center. To improve awareness about late effects, members of the
Czech Society of Pediatric Haematology/Oncology hold seminars
and publish articles about late effects.
Denmark
Information from the Danish Childhood Cancer Registry is
used to organize an SCP that summarizes potential late effects
and individual guidelines for long-term care. The SCP is included
in the survivor’s medical record and uploaded to a password-
protected webpage for up-to-date hospital records for personal
use or sharing with health providers.17 The research program,
Adult Life after Childhood Cancer in Scandinavia, comprising
more than 33,000 Nordic 1-year survivors of childhood cancer,18
has generated comprehensive data about treatment-related late
effects risks.
Table 2. Current Care for Survivors of Childhood Cancer Who Are Considered Adults Among Surveyed 18 Countries
Question AU BR CA CH CZ DE DK FR GB IL IN IT JP NL NZ SE TK US
Health care coverage
Universal or single payer x x x x x x x x x x x
Mixed, all adults with coverage x x x x
Mixed, most adults with coverage x x
Mixed, many adults without coverage x
Long-term survivors seen by physician familiar
with late effects (%)
Almost all (. 90)
Most (60-89) x
Approximately half (40-59) x x x
Some (10-39) x x x x x x x x x x x
Just a few (, 10) x x x
Where are adults seen?
. 75% at the cancer center x x x
Mixture: 50% center, 50% PCP x x x x x x x
, 25% at center x x x x x x x x
Use a risk-stratiﬁed approach
Yes x x x x x x x x x x
No x x x x x x x
Adults with an SCP (%)
Almost all (. 90) x*
Most (60-89)
About half (40-59) x x x x x x
Some (10-39) x x x x x
Just a few (, 10) x x x x x x
APPs
Yes, in almost all programs
Yes, but only in some programs x x x x x x x




PCP in the community x x x x x x x x x x x x x x x x x x
PCP communicates with center x x
Rare communication x x x x x x x x x x x x x x x x
Abbreviations: APP, advanced practice provider (ie, nurse practitioner or physician assistant); AU, Australia; BR, Brazil; CA, Canada; CH, Switzerland; CZ, Czech Republic;
DE, Germany; DK, Denmark; FR, France; GB, Great Britain; IL, Israel; IN, India; IT, Italy; JP, Japan; NL, Netherlands; NZ, New Zealand; PCP, primary care physician; SE,
Sweden; SCP, survivorship care plan; TK, Turkey; US, United States.
*Since 2006.
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France
Until adulthood, survivors of childhood cancer have regular
medical follow-up in French pediatric oncology units and receive
SCPs. For adults with a history of childhood cancer, follow-up is
heterogeneous. The French National Cancer Institute’s Cancer
Plan 2014-2019 has recognized survivorship care as a priority aim,
yet the absence of care coordination makes its achievement dif-
ﬁcult. To promote survivorship care, research programs such as the
French Childhood Cancer Survivor Study for Leukemia (LEA)19
and the French national breast and thyroid cancer screening
program (DeNaCaPST)20 have been developed. Two notable recent
major policy advances include coverage of after–cancer care ex-
penses by national health insurance and passage of the right to be
forgotten law, which prohibits the requirement to disclose a cancer
history in a loan or mortgage application.21
Germany
In Germany, survivorship care is available at all pediatric
cancer centers for survivors of childhood and adolescent cancer.
Multidisciplinary clinics for adult survivors of childhood cancer are
under development and aim to include oncology and general
providers who will network to ensure seamless and optimal af-
tercare. A clinical and research network between all German
survivorship clinics represents a uniﬁed approach for the future
prospective collection of aftercare data.
Great Britain
In Great Britain, the National Cancer Survivor Initiative was
recently organized to evaluate pathways for optimizing survivor-
ship care.22 Four aftercare models were deﬁned: cancer center–
delivered medical follow-up, shared care with local hospitals or
PCPs, specialist nurse-led supported management, and survivor
self-management. Key elements of successful risk-stratiﬁed care
were identiﬁed: comprehensive information transfer by SCPs, care
coordinators, effective transition between services, remote mon-
itoring systems that alert survivors to recommended testing, and
professional education. The principle of patient choice, or no
decision about me without me, was highlighted as fundamental to
the design and provision of services.
Israel
Israel has a universal health care system that insures all
survivors of pediatric and adult cancer and provides access to
treatment information via electronic health records. In hospital-
based survivorship clinics, the same records are used for SCP
creation and preparation for survivorship clinic appointments.
Transparency of medical records across different points of care
increases the efﬁciency of survivorship clinics and facilitates care
coordination. Most pediatric hematology and oncology programs
follow survivors within their clinic, usually without providing an
SCP, although a few medical centers have designated pediatric and/
or adult survivorship services, some of which include a formal
transition from pediatric to adult services.
India
In India, state-funded social or economic support for any
cancer care is either absent or limited, and access is strongly as-
sociated with variables such as caste, wealth, education, and ge-
ography.23 Training and resources for survivorship care are lacking.
No national or state-level policy addresses medical care, em-
ployment, or health insurance barriers for survivors of childhood
cancer. Furthermore, survivors of cancer in India are not eligible
for health or life insurance, regardless of time elapsed from
Table 3. Formal Efforts to Bridge Between Pediatric Oncology and Primary Care Physicians Among 18 Surveyed Countries
Question AU BR CA CH CZ DE DK FR GB IL IN IT JP NL NZ SE TK US
National effort to educate PCPs
Yes x x x
No, but one is in development x x x x x x x x x x
No, and nothing is in development x x x x x
Treating center sends PCP a copy of the SCP (%)
Almost always (. 90) x x x x x x
Most of the time (60-89) x
Approximately half of the time (40-59) x
Some of the time (10-39) x x x x x
Rarely (, 10) x x x x x
How often do PCPs contact center to get more
information? (%)
Very often (. 90)
Often (60-89)
Occasionally (40-59) x
Some of the time (10-39) x x x x x x x x
Rarely (, 10) x x x x x x x x x
Trustworthy internet site for PCPs to get information
No x x x x x x x x
Yes, they use a site in our country x x x x x x x x
Yes, but we direct them to an internet site outside of the
country
x x
Abbreviations: AU, Australia; BR, Brazil; CA, Canada; CH, Switzerland; CZ, Czech Republic; DE, Germany; DK, Denmark; FR, France; GB, Great Britain; IL, Israel; IN, India;
IT, Italy; JP, Japan; NL, Netherlands; NZ, New Zealand; PCP, primary care physician; SE, Sweden; SCP, survivorship care plan; TK, Turkey; US, United States.
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treatment. Several initiatives aim to improve this scenario: the Af-
ter Completion of Therapy clinic at Tata Memorial Hospital in
Mumbai has been following survivors of childhood cancer since
1991, with similar clinics developing at other high-volume centers;
Ugam, an advocacy and support group for survivors of childhood
cancer created under the umbrella of the Indian Cancer Society, has
engaged more than 250 Mumbai-based survivors; the Indian Cancer
Society’s Project PICASSO (Partnership in Cancer Survivorship
Optimization) promotes and facilitates hospital-based survivorship
clinics; and the Indian Pediatric Oncology group has formed a late-
effects study group to promote survivorship research.
Italy
In Italy, long-term care varies among the 53 Italian Associ-
ation of Pediatric Hematology and Oncology (AIEOP) centers on
the basis of local circumstances, availability of resources, and the
presence or absence of a formal transition process. To harmonize
follow-up care, Italy approved the use of the European Survivorship
Passport (SurPass) for patients with cancer at all AIEOP centers. The
SurPass is a web-based SCP, available in print and digital formats.
The SurPass can be automatically translated into several European
languages, is written in plain language, contains cancer history and
therapy information, and provides guidance on survivor-speciﬁc
long-term follow-up care. Organ-speciﬁc recommendations are
based on available internationally accepted guidelines (International
Late Effects of Childhood Cancer Guideline Harmonization Group/
PanCareSurFup) or according to institutional criteria. Data can be
shared through the Italian off-therapy registry.
Japan
For survivors of childhood cancer, most medical costs are
covered by universal insurance, with recent enactment of expansion
of coverage to 20 years of age. In an effort funded by the Ministry of
Health, Labor, and Welfare, the Japanese Society of Pediatric He-
matology and Oncology initiated health care team-training work-
shops, with the goal of achieving lifetime support for survivors of
child, adolescent, and young adult cancer. The Ministry has also
charged each prefectural administration with improving health and
ﬁnancial independence for children with chronic illness or cancer.
The Netherlands
In the Netherlands, all seven pediatric oncology centers have
established a survivorship clinic for survivors of childhood cancer.
Care focuses on education, early detection of late effects, and
coordination of care for all 5-year survivors of childhood cancer.
Risk-based surveillance is based on the Dutch Children’s Oncology
Group Long-Term Follow up Guidelines.24 In addition to these
efforts, survivors are actively recruited for participation in na-
tionally supported late-effect studies. In 2014, an effort was ini-
tiated to centralize childhood cancer as well as survivorship care to
the Princess Ma´xima Centre in Utrecht.
New Zealand
In New Zealand, survivorship care is available at three late-
effects clinics. Risk-stratiﬁed care for survivors younger than 21
years is supervised by the primary oncologist or an oncologist with
an interest in late effects, working in concert with a clinical nurse
specialist and/or psychologist. The National Child Cancer Network
supports a survivorship working group, provides overall governance
of the childhood cancer registry, and runs the Late Effects Assess-
ment Program online database (LEAP-IT). Together, these resources
offer New Zealand researchers access to a wealth of data for research
purposes. In addition, Network members contribute to many in-
ternational and local research initiatives to improve the outcomes of
children diagnosed with cancer, including a successful effort to
generate SCPs by linking registry data the LEAP-IT database.
Sweden
In Sweden, most childrenwith cancer receive follow-up care at
pediatric cancer centers until 18 years of age. Historically, follow-
up of adults treated for childhood cancer was poor, although two
survivorship centers have been established. In 2016, a new Swedish
National Guideline and Care Program for survivors was approved
and has been implemented by ﬁve of six childhood cancer treat-
ment centers. Notably, the Swedish National Guidelines recom-
mend a risk-stratiﬁed approach, such that many survivors can be
discharged to PCPs. The National Registry for late effects within
the Swedish Pediatric Cancer Registry, launched in 2012, provides
the patients with an SCP that can also be sent to primary and other
caregivers to facilitate shared care.
Switzerland
In Switzerland, children diagnosed with cancer before age 16
years are treated at specialized childhood cancer clinics afﬁliated
with the Swiss Pediatric Oncology Group. Most survivors receive
annual follow-up after completion of therapy for 5 to 10 years after
diagnosis, depending on the tumor, age at diagnosis, and local
pediatric cancer center. Until recently, Switzerland lacked stan-
dardized regional or national follow-up care and transition pro-
grams, so that follow-up care varied between hospitals or even
between consultants within a hospital. However, many ongoing
initiatives focus on survivorship care: Suivinet, a national online
information platform for survivors;25 a peer-to-peer mentoring
program linking survivors and patients with newly diagnosed dis-
ease; and, in Bern, the organization of SCPs using Baylor College of
Medicine’s Passport for Care.26 On a national level, implementation
of the European Survivorship Passport is prepared in a working
group of physicians, nurses, survivors, and parents. Last, a multi-
disciplinary survivorship clinic opened in Northern Switzerland
(Liestal) that offers examinations with specialists tailored to the
individual needs of survivors scheduled on a single day, during which
results, treatment recommendations, and the SCP are discussed.
Turkey
Turkey has struggled to provide care for survivors of child-
hood cancer because of the lack of survivorship clinics and formal
surveillance recommendations. The Turkish Pediatric Oncology
Group plans to develop long-term follow-up guidelines. In ad-
dition, both families and health care providers in Turkey are
unaware of late effects of cancer therapy. Therefore, an ongoing
effort to publicize and promote the guidelines is planned for
upcoming primary care meetings.
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United States
Although the majority of pediatric cancer centers in the
United States offer survivorship services, there is variability in the
resources available in these programs and the methods for
transition to adult providers.27 For survivors in the pediatric age
range, the care environment usually involves a specialized late-
effects program, with multidisciplinary staff supervised by a desig-
nated survivorship provider. For the remainder, evaluations are
undertaken in oncology clinics by the survivor’s primary oncologist.
Distribution of SCPs as well as risk-based surveillance for late effects
as recommended by the Children’s Oncology Group Guidelines28,29
represent the standard of care for survivors followed in pediatric
cancer programs. Only a minority of programs provide such ser-
vices for adults, with the majority facing transition of care to
community clinicians who generally have limited knowledge of
survivorship risks.30,31 In addition, health care of adult survivors of
childhood cancer is often fragmented and suboptimal because of
the frequent changing of health care plans by employers or sur-
vivors, the large deductibles associated with some health insurance
plans, and the general high cost of care.32 As changes in the Af-
fordable Care Act are debated, many survivors of cancer are
concerned that they may lose their coverage because of having
a preexisting condition.
DISCUSSION
As treatment and supportive care for childhood cancer has im-
proved worldwide, the survivor population has grown.1-3 In this
review, we present perspectives from across the globe on the
challenges and solutions, as well as the commonalities and ex-
ceptions, that unite patients and providers in childhood cancer
survivorship.
Some countries experience exceptional challenges in pro-
viding risk-based care. For example, Australia is an enormous
country (by land mass) that is home to a population of survivors of
childhood cancer separated by the tyranny of distance and without
an accepted framework to harmonize care.10 Childhood cancer
survivorship is only one of the challenges in that setting, although
scalable solutions are being sought.10,13,14,33 At the same time, our
Indian coauthor describes intolerable health care policies and
difﬁculties with health care delivery, including lack of health in-
surance for those with a history of cancer treatment.
Yet, common challenges can be identiﬁed as well. For those
considered children, care at the pediatric cancer center is the norm.
Nonetheless, apart from the Netherlands and New Zealand, young
adult survivors are not uniformly transitioned to adult care. In
Germany, the Working Group on Adolescents, Young Adults, and
Transition was established to address this and other gaps in care.
Their recent publication describes ongoing work to improve tran-
sitions to adult care and plans to establish a solid infrastructure for
transition in cooperation with health authorities that could provide
a model for other countries.34
Australia, the Czech Republic, and Great Britain provide SCPs
to almost all children with a history of cancer, but only New
Zealand has accomplished this goal for adult survivors of child-
hood cancer. Prior research in the United States and Canada
suggests that SCPs are well-received by survivors35 and are asso-
ciated with better knowledge of cancer treatment and surveillance
for late effects.36 A recent article describing Passport for Care
supports one widely used SCP model.26 Therefore, improving
transitions as well as promoting SCPs should remain international
priorities.
For the most part, care delivery solutions demonstrate
similar themes. In every country, clinicians caring for survivors of
childhood cancer are advancing efforts to educate providers and
patients. Many countries describe electronic or registry-based
methods for generating SCPs, and web-based survivorship
guidelines are universally invoked. Resource-poor settings tend to
have less to offer survivors, but care coordination and risk-based
care fall short even in more heavily resourced settings. Even
jurisdictions with universal health insurance describe large
numbers of survivors of childhood cancer without an SCP or
a provider who is familiar with late effects. Because survivorship
care has been associated with improved knowledge of cancer
treatment and late effects risk,37-40 fewer emergency room visits
and hospitalizations,16 as well as better surveillance practices,41
engaging patients and providers in this effort cannot be over-
valued.42 Cost-effectiveness analyses may facilitate use of recom-
mended testing.43,44
Finally, some countries describe unique and noteworthy
features of survivorship care. For example, in Denmark, a secure
website provides patient access to medical records and test re-
sults. In Ontario, Canada, survivorship clinics for adult survivors
of childhood cancer have been operational since 1999 and have
demonstrated beneﬁt to survivors in that province.15,16 Most
notably, survivors of childhood cancer in every country are asked
to be the guardians of their health care history, to share their SCP
with providers, and to self-advocate for risk-based care in every
setting. With the burden of risks and late effects these survivors
endure,45 requiring them to ﬁght for the care they need may be
too much to ask. Instead, providers and policy makers should
establish and endorse the knowledgeable and reliable health
systems infrastructure that survivors of childhood cancer
deserve.
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